To address controversies in the application of cost-effectiveness anal
ysis, we investigate the principles underlying the technique and discu
ss the implications for the evaluation of medical interventions. Using
a standard von Neumann-Morgenstern utility framework, we show how a c
ost-effectiveness criterion can be derived to guide resource allocatio
n decisions, and how it varies with age, gender, income level, and ris
k aversion. Although cost-effectiveness analysis can be a useful and p
owerful tool for resource allocation decisions, a uniform cost-effecti
veness criterion that is applied to a heterogeneous population level i
s unlikely to yield Pareto-optimal resource allocations.